Medtronic (MDT) Announces Expanded Indication for OsteoCool RF Ablation System

February 15, 2017 7:16 AM EST Send to a Friend
Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded indication for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login